Prevalence of Barrett’s Esophagitis in Erosive Esophagitis

Overview

About this study

The purpose of this study is to learn more about the prevalence of gastroesophageal reflux among patients with esophagitis using long term proton-pump-inhibitor use.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adults ages 18-90
LA grade B, C, or D esophagitis on EGD performed at Mayo Clinic
Repeat EGD preformed within 6 months at the Mayo Clinic

Exclusion Criteria:

Technically limited EGD
Evidence of achalasia or aperisalsis on high resolution esophageal manometry
Previous history of upper gastrointestinal surgery (e.g. fundoplication, bariatric surgery

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Karthik Ravi, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Karthik Ravi, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials